{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T20:31:55Z","timestamp":1786393915593,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005629","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaip.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:09:45Z","timestamp":1781309385000},"page":"1869-1880.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Social Determinants of Health in Newly Diagnosed Hereditary Angioedema and Their Impact on Healthcare Resource Utilization Outcomes"],"prefix":"10.1016","volume":"14","author":[{"given":"Alan P.","family":"Baptist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Allen","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigwa","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yecheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal","family":"Sing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob G.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salom\u00e9","family":"Juethner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.06.008_bib1","first-page":"S292","article-title":"Severity of hereditary angioedema, prevalence, and diagnostic considerations","volume":"24","author":"Bernstein","year":"2018","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2026.06.008_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.06.008_bib3","doi-asserted-by":"crossref","first-page":"S08","DOI":"10.2500\/aap.2020.41.200050","article-title":"Hereditary angioedema: epidemiology and burden of disease","volume":"41","author":"Lumry","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2026.06.008_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13023-024-03265-z","article-title":"Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review","volume":"19","author":"Guan","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2026.06.008_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","article-title":"Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency","volume":"130","author":"Bork","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib6","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2022-0188","article-title":"Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema","volume":"12","author":"Watt","year":"2023","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.jaip.2026.06.008_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fmed.2018.00022","article-title":"Hereditary angioedema: the economics of treatment of an orphan disease","volume":"5","author":"Lumry","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2026.06.008_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fmed.2017.00212","article-title":"Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema","volume":"4","author":"Bygum","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2026.06.008_bib9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.anai.2020.02.018","article-title":"Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States","volume":"124","author":"Banerji","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-021-01717-4","article-title":"Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey","volume":"16","author":"Mendivil","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2026.06.008_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2500\/aap.2021.42.200127","article-title":"Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema","volume":"42","author":"Castaldo","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2026.06.008_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jaip.2014.08.017","article-title":"Current medical management of hereditary angioedema: follow-up survey of US physicians","volume":"3","author":"Riedl","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.06.008_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.anai.2021.09.026","article-title":"Optimization of care for patients with hereditary angioedema living in rural areas","volume":"128","author":"Riedl","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib14","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1016\/j.jaip.2021.08.019","article-title":"Racial and ethnic disparities in the research and care of hereditary angioedema patients in the United States","volume":"9","author":"Sylvestre","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.06.008_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.anai.2023.03.005","article-title":"Challenges in the management of hereditary angioedema in urban and rural settings: results of a United States survey","volume":"130","author":"Meadows","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.anai.2025.01.007","article-title":"Hereditary angioedema: patient health care experiences within underrepresented racial and ethnic groups in the United States","volume":"134","author":"Craig","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/aorn.12722","article-title":"Back to basics: social determinants of health","volume":"110","author":"Spruce","year":"2019","journal-title":"AORN J"},{"key":"10.1016\/j.jaip.2026.06.008_bib18","author":"Guzman"},{"key":"10.1016\/j.jaip.2026.06.008_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13223-025-00999-8","article-title":"The International\/Canadian hereditary angioedema guideline","volume":"22","author":"Betschel","year":"2026","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib20","article-title":"The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities","volume":"9","author":"V\u00e1zquez","year":"2026","journal-title":"World Allergy Organization J"},{"key":"10.1016\/j.jaip.2026.06.008_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2500\/aap.2025.46.250029","article-title":"Adherence and persistence among patients with hereditary angioedema receiving long-term prophylaxis in the United States","volume":"46","author":"Zuraw","year":"2025","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2026.06.008_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.anai.2020.10.009","article-title":"Current medical management of hereditary angioedema: follow-up survey of US physicians","volume":"126","author":"Riedl","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36469\/jheor.2025.141171","article-title":"Effect of fresh frozen plasma infusion on hospital length of stay for patients with hereditary angioedema","volume":"12","author":"Khalid","year":"2025","journal-title":"J Health Econ Outcomes Res"},{"key":"10.1016\/j.jaip.2026.06.008_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329585","article-title":"Barriers and promoters to adapting research findings to clinical care in hereditary angioedema in the United States: a qualitative study","volume":"20","author":"Langmack","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2026.06.008_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.anai.2025.05.018","article-title":"Establishing a hereditary angioedema prevalence for the United States using a large administrative claims database","volume":"135","author":"Castaldo","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13223-021-00541-6","article-title":"Leveraging unstructured data to identify hereditary angioedema patients in electronic medical records","volume":"17","author":"Brouwer","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.008_bib27","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.37765\/ajmc.2023.89399","article-title":"Social determinants of health and high-cost utilization among commercially insured population","volume":"29","author":"Andreyeva","year":"2023","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2026.06.008_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/03007995.2021.1920380","article-title":"Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting","volume":"37","author":"Petrilla","year":"2021","journal-title":"Curr Med Res Opin"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982600499X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982600499X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T19:53:42Z","timestamp":1786391622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982600499X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S221321982600499X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.06.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Social Determinants of Health in Newly Diagnosed Hereditary Angioedema and Their Impact on Healthcare Resource Utilization Outcomes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}